(click image for PDF, or title for journal link)
See also: F1000 recommendation and Splicing may be therapeutically targetable in acute myeloid leukemia.
See also: Charting the "splice" routes to MDS, Splicing the MDS genome, and Understanding molecular pathways behind marrow disorders.
See also: F1000 recommendation.
See also: F1000 recommendation and The FedEx Factor.
See also: A Spliceosome Protein Is Essential for Glioma Stem Cell Viability.
See also: The Economist and Scientific American.
See also: Extensive regulation of NAGNAG alternative splicing: new tricks for the spliceosome? and New Insights from Existing Sequence Data: Generating Breakthroughs without a Pipette.
See also: Variable Transcription Factor Binding: A Mechanism of Evolutionary Change.